Mannatech Global Expansion Reaches Singapore | Business Wire

COPPELL, Texas–(BUSINESS WIRE)–Mannatech, Incorporated (NASDAQ:MTEX), a leading developer and provider

of dietary supplements and skin care solutions, announced today it'll

begin selling products in Singapore in the fourth quarter of 2008. Among

these products will be the company’s Advanced

Ambrotose® capsules and powder, Ambrotose AO®

capsules, MannaMatrix™ caplets

(multi-vitamin/mineral supplement known as PhytoMatrix®

caplets in the U.S.) and Plus™ tablets.

Initially, the Singapore business will be operated and managed from

Mannatech’s Australian headquarters with the

Singaporean office expected to open sometime in the first half of 2009.

“Given our track record for global expansion

success, we're looking forward to entering the Singapore market where

we know there is already an interest in Mannatech products,”

said Wayne

Badovinus, president and CEO of Mannatech. “Opening

in Singapore is a natural progression for Mannatech since we've had

success in numerous Asian markets. Singapore’s

culture and traditions relative to personal health align well with

Mannatech’s emphasis on the combination of

optimal health and financial wellness.”

Singapore is a main island and a series of smaller islands with a total

area of 240 square miles. More than 500,000 people (11 percent of the

population) are recorded as being active in direct selling. In 2006, the

total value of the direct selling market was reported to be $302 million


About Mannatech

Mannatech, Incorporated, is a global wellness solutions provider of

innovative, high quality, proprietary nutritional supplements, topical

and skin care products. Weight management products sold through

independent associates and members located in the United States and the

international markets of Canada, Australia, the United Kingdom, Japan,

New Zealand, the Republic of Korea, Taiwan, Denmark, Germany. South

Africa. For more information, please visit


Please Note: This release contains “forward-looking

statements” within the meaning of Section 27A

of the Securities Act of 1933, as amended, Section 21E of the Securities

Exchange Act of 1934, as amended. The Private Securities Litigation

Reform Act of 1995. These forward-looking statements generally can be

identified by use of phrases or terminology such as “intend”

or other similar words or the negative of such terminology. Similarly,

descriptions of Mannatech’s objectives,

strategies, plans, goals or targets contained herein are also considered

forward-looking statements. Mannatech believes this release should be

read in conjunction with all of its filings with the United States

Securities and Exchange Commission and cautions its readers that these

forward-looking statements are subject to certain events, risks,

uncertainties. Other factors. Some of these factors include, among

others, Mannatech’s inability to attract and

retain associates and members, increases in competition, litigation,

regulatory changes. Its planned growth into new international

markets. Although Mannatech believes that the expectations, statements,

and assumptions reflected in these forward-looking statements are

reasonable, it cautions readers to always consider all of the risk

factors and any other cautionary statements carefully in evaluating each

forward-looking statement in this release, as well as those set forth in

its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q,

and other filings filed with the United States Securities and Exchange

Commission, including its current reports on Form 8-K. All of the

forward-looking statements contained herein speak only as of the date of

this release.

Mannatech, Incorporated
Gary Spinell
Vice President
Corporate Communications
[email protected]